.jpg)
.png)
NLA News
On Sunday, Nov. 16, at the American Heart Association (AHA) Scientific Sessions, W. Virgil Brown, MD—Editor-in-Chief of the Journal of Clinical Lipidology and Founding President of the National Lipid Association (NLA)—facilitated and participated in a debate about cholesterol targets. The session (... more
View the Interactive Maps on www.CholesterolCounts.com for a Snapshot of Cholesterol Awareness Across the U.S. Bridgewater, NJ, and Tarrytown, NY, February 18, 2015 Despite the fact that high LDL-C (bad cholesterol) is a critical heart health factor for adults,1 71... more
The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia released today, focused on addressing evaluation, management, and monitoring of individuals living with dyslipidemia, including high blood cholesterol, elevated triglycerides, and elevated... more
Led by the efforts of Carl Orringer, MD, FNLA, the National Lipid Association (NLA) has released the updated NLA Self-Assessment Program (NLA-SAP). The new program — now available for purchase — improves on the already existing NLA product that will continue to enhance your... more
Alan Brown, MD, FNLA President It has been an honor to serve as the President of the National Lipid Association (NLA) for the 2018-19 organizational year, and I look forward to the rest of my term through the 2019 Scientific Sessions. I hope everyone had a wonderful holiday and want to... more
Further analysis from the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health (AIM-HIGH) trial was presented on November 15, 2011, at the American Heart Association (AHA) 2011 Scientific Sessions. The investigators echoed previous statements... more
The National Lipid Association is excited to announce a month-long extravaganza of virtual education, LipidPALOOZA, launching this September to celebrate National Cholesterol Education Month. There will be a variety of activities spread throughout the entire month and best of all, they will be... more
Experts in the field of clinical lipidology elected as officers of medical society focused on treating cardiometabolic disorders (JACKSONVILLE, FLA.)—The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election... more
Novartis received FDA approval for a label update that will allow for use of Leqvio ® (inclisiran) in certain patients at high risk of cardiovascular (CV) disease. This broader population allows for earlier Leqvio treatment in patients with elevated low-density lipoprotein cholesterol (LDL-C) and... more
During February—which is American Heart Month—the National Lipid Association (NLA) would like to recognize the important work underway by Million Hearts. This national initiative was launched by the Department of Health and Human Services in 2012, with the exciting goal of preventing 1 million... more